Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Jake Dunning

Dr Jake Dunning

Social media

Travelling to find suitable partner sites for rapid clinical trials in Guinea, Sierra Leone and Liberia, 2014
Using photography to transfer clinical trial data from within the red zone of an Ebola Treatment Centre

Jake Dunning

Senior Clinical Research Fellow

  • Senior Clinical Research Fellow in Emerging and High Consequence Infectious Diseases
  • Honorary Consultant in Infectious Diseases, Royal Free Hospital, London
  • Honorary Consultant, Reference Virology, UK Health Security Agency

My research focusses on emerging and high consequence infectious diseases, covering mechanisms of pathogenesis, characterisation of disease, and clinical trials of potential treatments. In 2014-2015, I was the clinical lead for ERGO’s Ebola treatment trials in West Africa. Subsequently, I was a consultant at Public Health England, with responsibility for respiratory  and enteric viruses, and latterly as the Head of Emerging Infections and Zoonoses and a National Incident Director for the COVID-19 pandemic. I’ve been involved in clinical, public health and research responses to viral haemorrhagic fevers, novel coronavirus infections, influenza, enterovirus infections, acute flaccid paralysis, orthopox infections, and Zika virus. I’ve been involved in the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) and the Clinical Characterisation Protocol since their inception. I co-lead projects in the NIHR Health Protection Research Units in Emerging and Zoonotic Infections and Respiratory Infections. I’m an Honorary Clinical Senior Lecturer in Respiratory Infections at Imperial College London, and an Honorary Clinical Associate Professor in Infection and Immunity at University College London.

I re-joined ERGO full-time in April 2021. Building on my experience in respiratory virus immunology, international outbreak preparedness and response, studying the mechanisms of disease pathogenesis and pathogen transmission, and clinical trials of potential treatments, I’ll be supporting multiple international ERGO projects, from COVID-19 to monkeypox to ‘disease X’. My research reflects the common goal of ERGO: conducting and enabling meaningful clinical research, with a focus on patient-centred projects and an aim to reduce the impact of emerging infections, epidemics and pandemics. In addition to working on current and persistent challenges, I’ll be working with the team and international partners on a process of continuous improvement, research-readiness and collaborative working, so that we are even better prepared to study and mitigate future outbreaks, wherever they occur.

Investigating differences in host immune responses to understand why severities of illness differ. Shown here are 231 transcripts in blood from influenza patients


Key publications

Recent publications

More publications